Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance
暂无分享,去创建一个
C. Almeras | D. Portalez | B. Malavaud | M. Soulié | G. Ploussard | M. Roumiguié | J. Beauval | M. Lesourd | R. Aziza | J. Gautier | G. Loison | A. Salin | C. Tollon | J. Assoun | M. Soulie